Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma
Authors:
- Joel A. BlockJBJoel A. Block
- Manuel O. DiazMDManuel O. Diaz
- Tsutomu NoboriTNTsutomu Nobori
- Steven GitelisSGSteven Gitelis
- Sven E. InerotSISven E. Inerot
- Anand P. IyerAIAnand P. Iyer
- 1 July 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 105 (1) , 77-90
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesionsCancer Genetics and Cytogenetics, 1993
- Cytogenetic Findings in a Metastasizing Primary Testicular ChondrosarcomaAmerican Journal of Surgical Pathology, 1993
- Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery.Journal of Bone and Joint Surgery, 1993
- A genetic model for colorectal tumorigenesisCell, 1990
- Deletions of Interferon Genes in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1990
- Complex cytogenetic aberrations in a well-differentiated chondrosarcomaCancer Genetics and Cytogenetics, 1989
- Cytogenetic Analysis of Melanocytes From Premalignant Nevi and MelanomasJNCI: Journal of the National Cancer Institute, 1988
- Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcomaCancer Genetics and Cytogenetics, 1988